SciELO - Scientific Electronic Library Online

 
vol.11 número4La consulta preconcepcional en Atención Primaria: Evaluación de la futura gestanteManejo del dolor neuropático: la gabapentina como opción índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Medifam

versión impresa ISSN 1131-5768

Resumen

RUIZ GARCIA, A. et al. Cross-sectional study: dyslipidaemia management in population between 65 and 75 years old. Medifam [online]. 2001, vol.11, n.4, pp.78-93. ISSN 1131-5768.

Background: due to variability of dyslipidaemia management by Primary Health Care physicians in population between 65 and 75 years old, is necessary a baseline evaluation. Objective: to describe the dyslipidaemia management by family physicians in population between 65 and 75 years old. Design: cross-sectional study. Material and method: from 841 patients between 65 and 75 years old with dyslipidaemia, and 16 Primary Health Care centers with 125 Primary Health Care physicians of Area 10 (National Institute of Health of Spain), were selected 551 patients and 38 Primary Health Care physicians by aleatory sampling in two stages. Mayor atherosclerotic risk factors (ARFs), coronary heart or atherosclerotic vascular diseases (CH/AVD), lipid profile, and dyslipidaemia management by physicians in accordance with National Cholesterol Education Program (NCEP II) were assessing. Results: using Chi square test, the 71.87 percent (CI95%: 37.88; 75.55) of patients had got ≥ 2 ARFs in addition dyslipidaemia, or suffered CH/AVD. Dyslipidaemia was managed with only diet in the 64.25 percent (CI95%: 60.07; 68.23), with HMG-CoA-reductase inhibitors in the 20.87 percent (CI95%: 17.60; 24.56), with fibric-acid derivates in the 12.16 percent (CI95%: 9.61; 15.25), and with bile acid sequestrants in the 2.36 percent (CI95%: 1.32; 4.11). The rate of the accurate dyslipidaemia management in this population was 47.91 percent (CI95%: 43,68; 52.71), decreased to 41.05 percent (CI95%: 35.33; 47.02) if patients had got ≥ 2 ARFs, and to 36.94 percent (CI95%: 28.12; 46.67) if they had got CH/AVD. Conclusions: dyslipidaemia management in population between 65 and 75 years old isn´t in accordance with NCEP II in the 52.09 percent, decreasing to 59.95 percent if patient has got ³2 ARFs, and to 63.06 percent if patient suffers CH/AVD. It is necessary to research what causes have influenced in this question.

Palabras clave : Family physicians; Hyperlipidaemia; Elderly.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons